Recombinant multi-species PRMT7 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine PRMT7 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes a member of the protein arginine N-methyltransferase family of proteins. The encoded enzyme transfers single methyl groups to arginine residues to generate monomethylarginines on histone proteins as well as other protein substrates. This enzyme plays a role in a wide range of biological processes, including neuronal differentiation, male germ line imprinting, small nuclear ribonucleoprotein biogenesis, and regulation of the Wnt signaling pathway. Mutations in this gene underlie multiple related syndromes in human patients characterized by intellectual disability, short stature and other features. The encoded protein may promote breast cancer cell invasion and metastasis in human patients. [provided by RefSeq, May 2017]
The Alternative Names of target: 4933402B05Rik,Histone-arginine N-methyltransferase PRMT7,PRMT7,Prmt7,Protein arginine N-methyltransferase 7,RGD1304869,SBIDDS,[Myelin basic protein]-arginine N-methyltransferase PRMT7

Target products collectionGo to PRMT7 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-T79501-Ag-1/ GM-Tg-hg-T79501-Ag-2 Human PRMT7 protein Human
GM-Tg-rg-T79501-Ag-1/ GM-Tg-rg-T79501-Ag-2 Rat PRMT7 protein Rat
GM-Tg-mg-T79501-Ag-1/ GM-Tg-mg-T79501-Ag-2 Mouse PRMT7 protein Mouse
GM-Tg-cynog-T79501-Ag-1/ GM-Tg-cynog-T79501-Ag-2 Cynomolgus/Rhesus macaque PRMT7 protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-T79501-Ag-1/ GM-Tg-felg-T79501-Ag-2 Feline PRMT7 protein Feline
GM-Tg-cang-T79501-Ag-1/ GM-Tg-cang-T79501-Ag-2 Canine PRMT7 protein Canine
GM-Tg-bovg-T79501-Ag-1/ GM-Tg-bovg-T79501-Ag-2 Bovine PRMT7 protein Bovine
GM-Tg-equg-T79501-Ag-1/ GM-Tg-equg-T79501-Ag-2 Equine PRMT7 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-T79501-Ag-1/ GM-Tg-hg-T79501-Ag-2; GM-Tg-rg-T79501-Ag-1/ GM-Tg-rg-T79501-Ag-2;
GM-Tg-mg-T79501-Ag-1/ GM-Tg-mg-T79501-Ag-2; GM-Tg-cynog-T79501-Ag-1/ GM-Tg-cynog-T79501-Ag-2;
GM-Tg-felg-T79501-Ag-1/ GM-Tg-felg-T79501-Ag-2; GM-Tg-cang-T79501-Ag-1/ GM-Tg-cang-T79501-Ag-2;
GM-Tg-bovg-T79501-Ag-1/ GM-Tg-bovg-T79501-Ag-2; GM-Tg-equg-T79501-Ag-1/ GM-Tg-equg-T79501-Ag-2
Products Name PRMT7 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name PRMT7
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine PRMT7 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.